Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 26.35
- Piotroski Score 5.00
- Grade Overweight
- Symbol (CORT)
- Company Corcept Therapeutics Incorporated
- Price $43.92
- Changes Percentage (1.48%)
- Change $0.64
- Day Low $42.81
- Day High $44.02
- Year High $44.37
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/30/2024
- Fiscal Year End N/A
- Average Stock Price Target $55.00
- High Stock Price Target $78.00
- Low Stock Price Target $38.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.05
- Trailing P/E Ratio 31.72
- Forward P/E Ratio 31.72
- P/E Growth 31.72
- Net Income $106.14 M
Income Statement
Quarterly
Annual
Latest News of CORT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Rep. Alexandria Ocasio-Cortez says NYC Mayor Eric Adams should resign "for the good of the city"
Rep. Alexandria Ocasio-Cortez believes Eric Adams should resign as NYC mayor due to ongoing federal investigations. Despite numerous resignations in his administration, Adams remains confident in his ...
By CBS News | 4 days ago -
Today in History: September 25, Military escorts Little Rock Nine into Central High
On Sept. 25, 1957, Black students escorted to school by the U.S. Army in Little Rock, Arkansas. In 1513, Balboa saw the Pacific Ocean. In 1789, Congress passed 12 amendments, 10 became the Bill of Rig...
By AP NEWS | 5 days ago -
Turner prize 2024 review - vitality, surprise ... and a Ford Escort in a doily
The Turner Prize exhibition at Tate Britain features diverse and engaging works, including Jasleen Kaur's red Ford Escort installation, Delaine Le Bas's intricate pieces, Pio Abad's historical reinter...
By The Guardian | 6 days ago
